Journal articleNat Cancer2026
Gemcitabine and nab-paclitaxel with or without the VDR agonist paricalcitol for metastatic pancreatic cancer: a randomized, multiarm, run-in phase trial.
- Journal
- Nat Cancer
- Published
- 25 May 2026
- Citations
- 1
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Trials 1
Grants 5
- Regulation and targeting of tumor cell states and plasticity in pancreatic cancer K08CA260442↗
- Core 3: Mouse Models Core (MM Core) P01CA265762↗
- Pancreatitis-induced initiation of early onset pancreatic cancer P30CA014195↗
- Project 3 - Improving Therapy for DNA-Damage Deficient Pancreatic Adenocarcinoma P50CA127003↗
- Altered metabolism and machine learning for pancreatic cancer early detection U01CA210171↗